Company / Current Liabilities
Ovid Therapeutics Inc. Current Liabilities History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$8.3M
FY2025
5-year range
$7.0M / $11.5M
FY2022-FY2025
Trend
-21.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $11M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025 with a 3-year CAGR of +5.8%.
Improved from $11M to $8M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, current liabilities decreased 21.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.3M | -21.2% |
| FY2024 | $10.5M | -8.3% |
| FY2023 | $11.5M | +64.1% |
| FY2022 | $7.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026